Abstract: The invention relates to a process for treating, with a plasma, a composition comprising at least a first compound and a second compound, characterized in that said process comprises at least: generating, within an enclosure, a non-equilibrium plasma flow from a gas present in said enclosure, and treating the composition contained in said enclosure with said non-equilibrium plasma flow so as to extract at least a portion of said first compound.

Abstract: A system and method for voice control of a media playback device is disclosed. The method includes receiving an instruction of a voice command, converting the voice command to text, transmitting the text command to the playback device, and having the playback device execute the command. An instruction may include a command to play a set of audio tracks, and the media playback device plays the set of audio tracks upon receiving the instruction.

Abstract: A system and method for voice control of a media playback device is disclosed. The method includes receiving an instruction of a voice command, converting the voice command to text, transmitting the text command to the playback device, and having the playback device execute the command. An instruction may include a command to play a set of audio tracks, and the media playback device plays the set of audio tracks upon receiving the instruction.

Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Abstract: Compositions and methods relating to a panel of antigen biomarkers for the early detection of ovarian cancer. The compositions and methods encompass antigen biomarkers coupled to a substrate, with the biomarkers being selected from the group consisting of one or more of ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3.

Abstract: Methods for identifying antigens as potential biomarkers for the early detection of ovarian cancer, as well as kits for utilizing said antigens as biomarkers and in personalized medicine/therapeutics assessment. Protein microarrays displaying full-length candidate antigens were developed and sequentially screening to select candidate autoantibody biomarkers to limit the false discovery rate inherent to large-scale proteomic screening.

Abstract: Techniques for accessing and configuring meeting attributes are described. In at least some embodiments, a meeting object is leveraged to store meeting attributes and pointers to meeting-related content. A meeting object, for instance, can serve as a manifest for meeting attributes. According to various embodiments, different entities (e.g., applications, services, and so forth) can access a meeting object to ascertain and/or configure meeting attributes for a meeting. For instance, a meeting application programming interface (API) can be employed to enable different entities to interact with a meeting object in various ways.

Abstract: The present invention is directed to diagnostic methods based upon the detection of peptides derived from the degradation of CA125. In particular, it is concerned with assays of urine samples collected from women for the purpose of determining whether they are at increased risk for having ovarian cancer, have decreased their risk as the result of clinical or non-clinical procedures, to monitor the efficacy of a treatment method, or to determine whether cancer has recurred or advanced.

Abstract: The invention is directed to assays of CA-125 immune complexes that can be used diagnostically. It also includes glass or plastic plates or slides on which the monoclonal antibodies against CA-125 have been immobilized and kits containing these plates or slides.

Abstract: An article of seating furniture that is particularly desirable for use with bariatric patients is disclosed. The seating furniture includes a seat portion that includes a front seating area and a rear seating area. The front seating area is defined by a generally semi-elliptical front perimeter surface while the rear seating area is defined by a different, generally semi-elliptical rear perimeter surface. The surface area of the front seating area is less than the surface area of the rear seating area to provide enhanced ingress and egress for a bariatric patient. The seating furniture includes a back portion and two pair of support legs that further enhance the desirability of the seating furniture for a bariatric patient.

Abstract: The present invention is directed to diagnostic methods based upon the detection of peptides derived from the degradation of CA125. In particular, it is concerned with assays of urine samples collected from women for the purpose of determining whether they are at increased risk for having ovarian cancer, have decreased their risk as the result of clinical or non-clinical procedures, to monitor the efficacy of a treatment method, or to determine whether cancer has recurred or advanced.

Abstract: An article of seating furniture that is particularly desirable for use with bariatric patients is disclosed. The seating furniture includes a seat portion that includes a front seating area and a rear seating area. The front seating area is defined by a generally semi-elliptical front perimeter surface while the rear seating area is defined by a different, generally semi-elliptical rear perimeter surface. The surface area of the front seating area is less than the surface area of the rear seating area to provide enhanced ingress and egress for a bariatric patient. The seating furniture includes a back portion and two pair of support legs that further enhance the desirability of the seating furniture for a bariatric patient.